Blockchain’s potential to Revolutionize Genomic Data in Healthcare Settings

By: SBIP and Blockchain Association Singapore (Ms Kon Sui Jin)

29 April 2024

Blockchain’s potential to Revolutionize Genomic Data in Healthcare Settings

Introduction:


In the ever-evolving landscape of healthcare, the integration of blockchain technology in the collection, storage, and analysis of genomic innovation stands as a beacon of innovation and transformation. Blockchain's decentralized and immutable ledger properties offer users unparalleled security, transparency, and interoperability, addressing critical challenges in managing sensitive and private genomic information.

In this post, we will explore real-life examples of how blockchain is powering the applications that drive healthcare innovations from genomic data, and the various implications of such. We will also delve into how blockchain is poised to revolutionize the entire healthcare continuum, specifically touching on areas such as epidemiology, drug and medical device discovery, healthcare service planning and delivery, as well as healthcare insurance pricing, all of which aim to ultimately benefit the owners, users, and consumers of genomic data.


Real-Life Examples of Blockchain in Genomic Data:



Decentralised health data and use of AI: In Singapore, homegrown biotech company MediLOT is a dual blockchain-based Electronic Health Records platform that allows individual patients to grant healthcare providers, research institutions and pharmaceuticals access to their encrypted medical data by indicating the storage location. This is a highly secure solution which adheres to GDPR and other stringent data privacy regulations. Patients will be incentivized and empowered to permit the usage of their data to facilitate research. Allowing patients and doctors to fully unlock the value of their health data for better diagnoses and more effective treatments.

Secure and Transparent Genomic Data Collection: Companies like Nebula Genomics empower individuals to securely contribute their genomic data to research initiatives through blockchain-enabled platforms. By providing individuals with ownership and control over their data while ensuring privacy and security through encryption and decentralized storage, Nebula accelerates genomic research and fosters collaboration among stakeholders.

Immutable Storage and Traceability: EncrypGen, a US-based bio-tech company, utilizes blockchain to ensure the integrity and traceability of genomic data. By recording each transaction on a tamper-proof ledger, EncrypGen, now acquired by IndyGene, guarantees transparency and trust, essential for collaborative research efforts and regulatory compliance, especially when such data is shared across borders, and various privacy legislation such as the GDPR come into effect. In providing such a service, the scientific discovery process can be sped up, and life-saving products brought to market sooner, rather than later. Furthermore, subjects who consent to the use of their genomic data in clinical trials are compensated for the release of such data, helping subjects to monetize their own genetic data, rather than allowing pharmaceutical companies to benefit commercially from this data without correctly attributing the costs to the source of the data.

Enhanced Data Analysis and Insights: Coral Health leverages blockchain to integrate genomic and clinical data, enabling researchers to derive actionable insights for personalized medicine and targeted interventions. By analyzing diverse datasets on a decentralized platform, companies like Coral Health can help accelerate drug discovery, individualize clinical protocols and produce improved patient outcomes.


Implications for the Healthcare Continuum:


Advancing Epidemiological Research: Blockchain-enabled genomic data sharing facilitates real-time collaboration among researchers while minimizing risks of loss of privacy, thereby enabling early detection, surveillance, and mitigation of infectious diseases and pandemics. Through this aggregation and analysis of genomic datasets, epidemiologists are able to gain insights into disease transmission, genetic predispositions, and population health trends. These in turn then lead to enhanced public health preparedness and response strategies.

Transforming Healthcare Delivery: Personalized medicine revolutionizes healthcare delivery by tailoring diagnostics, therapies, and preventive interventions to individual genetic profiles. Integrating genomic data with electronic health records and telemedicine platforms all driven by the qualities and power of the Blockchain enhances treatment outcomes, reduces costs, and fosters greater patient engagement and empowerment through the assurance of best fit for the individual.

Institutions without Borders - Accelerating Innovation in Drug and Medical Device Discovery: Blockchain accelerates drug discovery and medical device development through the facilitation of secure data sharing and collaboration among researchers. By analyzing, yet retaining individual ownership of genomic and clinical datasets on decentralized platforms, researchers are able to collaboratively, and across diverse institutions, identify novel targets, validate hypotheses, and expedite the translation of scientific discoveries into clinically appropriate therapies and technologies.

Reshaping Pricing and Availability of Healthcare Insurance: Blockchain-powered risk assessment tools based on genomic data enable insurers to offer more accurate and personalized insurance pricing. By predicting disease likelihood and adjusting premiums accordingly, insurers promote equity, transparency, and proactive health management among policyholders.


Benefits for Owners, Users, and Consumers of Genomic Data:


Ownership and Control: Individuals gain ownership and control over their personal genomic data, empowering them to make informed decisions about its use in research, healthcare services, and insurance premiums.

Privacy and Security: Blockchain ensures the privacy and security of genomic data through encryption, decentralized storage, and consent mechanisms, protecting sensitive information from unauthorized access or manipulation.

Empowerment and Collaboration: By participating in blockchain-enabled platforms, individuals are able to be directly and accurately compensated for their contributions to scientific advancements and personalized healthcare initiatives with adequate privacy protections while fostering collaboration and trust among stakeholders.



The integration of blockchain technology in genomic data collection, storage, and analysis heralds a new era of innovation and transformation in healthcare. By leveraging blockchain's capabilities to securely store, share, and analyze genomic data, we unlock unprecedented opportunities for advancing epidemiology, healthcare delivery, drug discovery, and the access to right-sized healthcare insurance.

Moreover, the benefits extend to the owners, users, and consumers of genomic data, empowering individuals, enhancing privacy and security, and fostering partnerships and trust in the healthcare ecosystem. As we embark on this journey, collaboration among stakeholders, regulatory frameworks, and ethical considerations will be essential to realizing the full potential of blockchain in shaping the future of healthcare for generations to come.

The security and peace of mind that storing this data on blockchain provides will ultimately translate into an increased number of people willing to undergo genomic sequencing, thereby improving the diversity and therefore quality of genomic data, ultimately giving scientists and researchers a more complete understanding of the human genome. The implications of which are far reaching, given the uncertainties of our environment today, that we may one day need to reach into this vast catalogue of the human genetic code to preserve our very existence on this planet.



The co-author of this blog post, Ms Kon Sui Jin, is currently the Executive Director at Blockchain Association Singapore and has a thoroughly developed view and understanding of the provision of healthcare services due to her prior service in the Singapore Public Healthcare system.

At the Singapore Blockchain Innovation Programme (SBIP), we are dedicated to exploring the potential of blockchain technology and driving innovation in this exciting field. Through our community events, workshops, and partnerships, we aim to connect blockchain enthusiasts and innovators to create a vibrant ecosystem for blockchain development.

So if you're interested in learning more about the world of blockchain technology and its potential applications, join us at SBIP!


SBIP Team
Visit and Follow us at:

Copyright 2024 © Singapore Blockchain Innovation Programme. All rights reserved.